Literature DB >> 25722113

Dormancy activation mechanism of oral cavity cancer stem cells.

Xiang Chen1, Xin Li, Baohong Zhao, Dehao Shang, Ming Zhong, Chunfu Deng, Xinshan Jia.   

Abstract

Radiotherapy and chemotherapy are targeted primarily at rapidly proliferating cancer cells and are unable to eliminate cancer stem cells in the G0 phase. Thus, these treatments cannot prevent the recurrence and metastasis of cancer. Understanding the mechanisms by which cancer stem cells are maintained in the dormant G0 phase, and how they become active is key to developing new cancer therapies. The current study found that the anti-cancer drug 5-fluorouracil, acting on the oral squamous cell carcinoma KB cell line, selectively killed proliferating cells while sparing cells in the G0 phase. Bisulfite sequencing PCR showed that demethylation of the Sox2 promoter led to the expression of Sox2. This then resulted in the transformation of cancer stem cells from the G0 phase to the division stage and suggested that the transformation of cancer stem cells from the G0 phase to the division stage is closely related to an epigenetic modification of the cell.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25722113     DOI: 10.1007/s13277-015-3225-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

1.  Oct-3/4 is a dose-dependent oncogenic fate determinant.

Authors:  Sharon Gidekel; Galina Pizov; Yehudit Bergman; Eli Pikarsky
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

Review 2.  Brain tumour stem cells.

Authors:  Angelo L Vescovi; Rossella Galli; Brent A Reynolds
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

3.  Distinct contribution of stem and progenitor cells to epidermal maintenance.

Authors:  Guilhem Mascré; Sophie Dekoninck; Benjamin Drogat; Khalil Kass Youssef; Sylvain Broheé; Panagiota A Sotiropoulou; Benjamin D Simons; Cédric Blanpain
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

4.  Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression.

Authors:  P H Jones; F M Watt
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

5.  Enrichment for murine keratinocyte stem cells based on cell surface phenotype.

Authors:  H Tani; R J Morris; P Kaur
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

6.  Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

Authors:  Lubna Patrawala; Tammy Calhoun; Robin Schneider-Broussard; Jianjun Zhou; Kent Claypool; Dean G Tang
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

7.  Characterization of a side population of cancer cells from human gastrointestinal system.

Authors:  Naotsugu Haraguchi; Tohru Utsunomiya; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Graham F Barnard; Masaki Mori
Journal:  Stem Cells       Date:  2005-10-20       Impact factor: 6.277

8.  Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins.

Authors:  Takaya Ichimura; Sugiko Watanabe; Yasuo Sakamoto; Takahiro Aoto; Naoyuki Fujita; Mitsuyoshi Nakao
Journal:  J Biol Chem       Date:  2005-02-02       Impact factor: 5.157

9.  Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.

Authors:  V Häyry; L K Mäkinen; T Atula; H Sariola; A Mäkitie; I Leivo; H Keski-Säntti; J Lundin; C Haglund; J Hagström
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

View more
  6 in total

1.  Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.

Authors:  Li-Yun Yang; Chang-Yu He; Xue-Hua Chen; Li-Ping Su; Bing-Ya Liu; Hao Zhang
Journal:  Oncotarget       Date:  2016-07-26

2.  Properties and feasibility of using cancer stem cells in clinical cancer treatment.

Authors:  Xiao-Mei Gao; Rui Zhang; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

Review 3.  Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis.

Authors:  Xiao-Lei Gao; Mei Zhang; Ya-Ling Tang; Xin-Hua Liang
Journal:  Onco Targets Ther       Date:  2017-10-27       Impact factor: 4.147

Review 4.  Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Biomed Res Int       Date:  2017-07-12       Impact factor: 3.411

Review 5.  Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review.

Authors:  Ranui Baillie; Swee T Tan; Tinte Itinteang
Journal:  Front Oncol       Date:  2017-06-02       Impact factor: 6.244

6.  Fbxw7 and Skp2 Regulate Stem Cell Switch between Quiescence and Mitotic Division in Lung Adenocarcinoma.

Authors:  Wenzhu Zhang; Zihan Ren; Lanling Jia; Xin Li; Xinshan Jia; Yuchen Han
Journal:  Biomed Res Int       Date:  2019-08-25       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.